Page 77 - IJB-6-4
P. 77

Soman and Vijayavenkataraman
              environments. Hence, development of suitable     9.   Sridharan  R,  Tchieu  J, Mason MJ,  et  al., 2009, Role  of
              post-processing strategies  such as  integrated      the  Murine  Reprogramming  Factors  in  the  Induction
              perfusion bioreactor systems becomes necessary.      of  Pluripotency.  Cell,  136:364–77.  DOI: 10.1016/j.
           •  Pathway for clinical translation: A coordinated      cell.2009.01.001.
              effort  between  the  clinicians,  scientists,  and
              bioengineers  in solving the  technological      10.  Kim JB, Greber B,  Arazo-Bravo MJ,  et  al., 2009, Direct
              limitations and support from the government          Reprogramming  of Human Neural Stem Cells by OCT4.
              and policy-makers  would go a long way in            Nature, 461:649–53. DOI: 10.1038/nature08436.
              establishing a pathway for clinical translation   11.  Stadtfeld M, Hochedlinger K, 2010, Induced Pluripotency:
              of bioprinted iPSC-derived  tissues for              History, Mechanisms,  and  Applications.  Genes Dev,
              regenerative medicine, disease modeling and
              drug testing.                                        24:2239–63. DOI: 10.1101/gad.1963910.
                                                               12.  Yee JK, 2010, Turning Somatic Cells into Pluripotent Stem
           Conflicts of interest                                   Cells. Nat Educ, 3:25.
                                                               13.  Mertens  J, Reid  D, Lau  S,  et  al., 2018, Aging in  a  Dish:
           The authors declare no conflict of interest.            iPSC-Derived and Directly  Induced Neurons for Studying

           References                                              Brain Aging and Age-Related Neurodegenerative Diseases.
                                                                   Annu Rev Genet, 52:271–93. DOI: 10.1146/annurev-
           1.   Takahashi  K,  Yamanaka  S, 2006, Induction  of Pluripotent   genet-120417-031534.
               Stem Cells from Mouse Embryonic  and  Adult Fibroblast   14.  Penney  J, Ralvenius  WT,  Tsai  LH,  2019,  Modeling
               Cultures   by   Defined   Factors.   Cell,  126:663–76.  Alzheimer’s Disease with iPSC-Derived Brain Cells.  Mol
               DOI: 10.1016/j.cell.2006.07.024.                    Psychiatry, 25:148–67. DOI: 10.1038/s41380-019-0468-3.
           2.   Yu J, Vodyanik MA, Smuga-Otto K, et al., 2007, Thomson,   15.  Chen IY, Matsa E, Wu JC, 2016, Induced Pluripotent Stem
               Induced Pluripotent Stem Cell Lines Derived from Human   Cells: At the Heart of Cardiovascular Precision Medicine. Nat
               Somatic  Cells.  Science, 318:1917–20. DOI: 10.1126/  Rev Cardiol, 13:333–49. DOI: 10.1038/nrcardio.2016.36.
               science.1151526.                                16.  Koch L, Deiwick  A, Franke  A,  et al., 2018, Laser
           3.   Zhang Y, Chen K, Sloan SA, et al., 2004, An RNA-sequencing   Bioprinting  of Human Induced Pluripotent  Stem Cells
               Transcriptome and Splicing Database of Glia, Neurons, and   the  Effect  of  Printing  and  Biomaterials  on  Cell  Survival,
               Vascular Cells of the Cerebral Cortex. J Neurosci, 34:11929–  Pluripotency, and Differentiation. Biofabrication, 10:035005.
               47. DOI: 10.1523/jneurosci.1860-14.2014.            DOI: 10.1088/1758-5090/aab981.
           4.   Chappell J, Dalton S, 2013, Roles for MYC in the   17.  Maiullari F, Costantini M, Milan M, et al., 2018, A Multi-
               Establishment and Maintenance of Pluripotency. Cold Spring   cellular  3D Bioprinting  Approach for  Vascularized  Heart
               Harb. Perspect Med, 3:a014381. DOI: 10.1101/cshperspect.  Tissue Engineering Based on HUVECs  and iPSC-Derived
               a014381.                                            Cardiomyocytes.  Sci  Rep,  8:13532.  DOI: 10.1038/s41598-
           5.   Zhang P, Zhang X, Brown J, et al., 2010, Global Healthcare   018-31848-x.
               Expenditure on Diabetes for 2010 and 2030. Diabetes Res   18.  Yeung E, Fukunishi  T, Bai  Y,  et al., 2019, Cardiac
               Clin Pract, 87:293–301. DOI: 10.1016/j.diabres.2010.12.025.  Regeneration Using Human-induced Pluripotent Stem Cell-
           6.   Han JW, Yoon YS, 2011, Induced Pluripotent  Stem Cells:   derived Biomaterial-free 3D-bioprinted Cardiac Patch In Vivo.
               Emerging  Techniques for Nuclear  Reprogramming.    J Tissue Eng Regen Med, 13:2031-9. DOI: 10.1002/term.2954.
               Antioxidants  Redox Signal, 15:1799–820. DOI: 10.1089/  19.  Faulkner-Jones  A, Fyfe C, Cornelissen DJ,  et al., 2015,
               ars.2010.3814.                                      Bioprinting of Human Pluripotent Stem Cells and their
           7.   An Z, Liu P, Zheng J, et al., 2019, Sox2 and Klf4 as the Functional   Directed  Differentiation  into  Hepatocyte-like  Cells  for  the
               Core in Pluripotency Induction without Exogenous Oct4. Cell   Generation of Mini-livers in 3D. Biofabrication, 7:044102.
               Rep, 29:1986–2000. DOI: 10.1016/j.celrep.2019.10.026.  doi.org/10.1088/1758-5090/7/4/044102.
           8.   Chen IP, Fukuda K, Fusaki  N,  et  al., 2013, Induced   20.  Nguyen  HX,  Hooshmand  MJ, Saiwai  H,  et  al.,  2017,
               Pluripotent Stem Cell Reprogramming by Integration-free   Systemic Neutrophil Depletion Modulates the Migration and
               Sendai Virus Vectors from Peripheral Blood of Patients with   Fate  of Transplanted  Human Neural  Stem  Cells  to Rescue
               Craniometaphyseal Dysplasia. Cell Reprogram, 15:503–13.   Functional Repair. J Neurosci, 37:9269–87. DOI: 10.1523/
               DOI: 10.1089/cell.2013.0037.                        jneurosci.2785-16.2017.
                                       International Journal of Bioprinting (2020)–Volume 6, Issue 4        73
   72   73   74   75   76   77   78   79   80   81   82